MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circheartfailure.122.009714

Медицинская библиотека · Circulation. Heart failure · 2022

Clinician and Algorithmic Application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network Registry.

Patel Siddharth M, Berg David D, Bohula Erin A, Baird-Zars Vivian M, Barnett Christopher F, Barsness Gregory W, Chaudhry Sunit-Preet, Daniels Lori B, van Diepen Sean, Ghafghazi Shahab, Goldfarb Michael J, Jentzer Jacob C, Katz Jason N, Kenigsberg Benjamin B, Lawler Patrick R, Miller P Elliott, Papolos Alexander I, Park Jeong-Gun, Potter Brian J, Prasad Rajnish, Singam N Sarma V, Sinha Shashank S, Solomon Michael A, Teuteberg Jeffrey J, Morrow David A, CCCTN Investigators

Многоцентровое исследованиеСтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

BACKGROUND

Algorithmic application of the 2019 Society of Cardiovascular Angiography and Intervention (SCAI) shock stages effectively stratifies mortality risk for patients with cardiogenic shock. However, clinician assessment of SCAI staging may differ. Moreover, the implications of the 2022 SCAI criteria update remain incompletely defined.

METHODS

The Critical Care Cardiology Trials Network is a multicenter registry of cardiac intensive care units (CICUs). Between 2019 and 2021, participating centers (n=32) contributed at least a 2-month snapshot of consecutive medical CICU admissions. In-hospital mortality was assessed across 3 separate staging methods: clinician assessment, Critical Care Cardiology Trials Network algorithmic application of the 2019 SCAI criteria, and a revision of the Critical Care Cardiology Trials Network application using the 2022 SCAI criteria.

RESULTS

Of 9612 admissions, 1340 (13.9%) presented with cardiogenic shock with in-hospital mortality of 35.2%. Both clinician and algorithm-based staging using the 2019 SCAI criteria identified a stepwise gradient of mortality risk (stage C-E: 19.0% to 83.7% and 14.6% to 52.2%, respectively; Ptrend<0.001 for each). Clinician assignment of SCAI stages identified higher risk patients compared with algorithm-based assignment (stage D: 49.9% versus 29.3%; stage E: 83.7% versus 52.2%). Algorithmic application of the 2022 SCAI criteria, with incorporation of the vasoactive-inotropic score, more closely approximated clinician staging (mortality for stage C-E: 21.9% to 70.5%; Ptrend<0.001).

CONCLUSIONS

Both clinician and algorithm-based application of the 2019 SCAI stages identify a stepwise gradient of mortality risk, although clinician-staging may better allocate higher risk patients into advanced SCAI stages. Updated algorithmic staging using the 2022 SCAI criteria and vasoactive-inotropic score further refines risk stratification.

Для цитирования: Patel Siddharth M, Berg David D, Bohula Erin A, Baird-Zars Vivian M, Barnett Christopher F, Barsness Gregory W, Chaudhry Sunit-Preet, Daniels Lori B, van Diepen Sean, Ghafghazi Shahab, Goldfarb Michael J, Jentzer Jacob C, Katz Jason N, Kenigsberg Benjamin B, Lawler Patrick R, Miller P Elliott, Papolos Alexander I, Park Jeong-Gun, Potter Brian J, Prasad Rajnish, Singam N Sarma V, Sinha Shashank S, Solomon Michael A, Teuteberg Jeffrey J, Morrow David A, CCCTN Investigators. Clinician and Algorithmic Application of the 2019 and 2022 Society of Cardiovascular Angiography and Intervention Shock Stages in the Critical Care Cardiology Trials Network Registry.. Circulation. Heart failure. 2022. DOI: 10.1161/circheartfailure.122.009714.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.